Skip to main content
logo
Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.640
+0.080 (3.13%)
May 5, 2026, 11:01 AM EDT - Market open

Organogenesis Holdings Revenue

In the year 2025, Organogenesis Holdings had annual revenue of $564.17M with 17.04% growth. Organogenesis Holdings had revenue of $225.61M in the quarter ending December 31, 2025, with 78.13% growth.

Revenue (ttm)
$564.17M
Revenue Growth
+17.04%
P/S Ratio
0.58
Revenue / Employee
$660,619
Employees
854
Market Cap
339.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025564.17M82.13M17.04%
Dec 31, 2024482.04M48.90M11.29%
Dec 31, 2023433.14M-17.75M-3.94%
Dec 31, 2022450.89M-16.47M-3.52%
Dec 31, 2021467.36M129.06M38.15%
Dec 31, 2020338.30M77.32M29.63%
Dec 31, 2019260.98M67.53M34.91%
Dec 31, 2018193.45M-5.06M-2.55%
Dec 31, 2017198.51M59.78M43.09%
Dec 31, 2016138.73M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Emergent BioSolutions676.80M
Evolus297.18M
Aurora Cannabis272.13M
Akebia Therapeutics236.20M
Organigram Global204.21M
Canopy Growth203.04M
Kamada180.46M
Lifecore Biomedical129.46M
Revenue Rankings

ORGO News

More News